Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vanadate activates platelets by enhancing arachidonic acid release

A McNicol1, C Robertson, J M Gerrard

  • 1Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada.

Blood
|May 1, 1993
PubMed
Summary

Vanadate, a tyrosine phosphohydrolase inhibitor, triggers platelet aggregation and protein phosphorylation by promoting arachidonic acid release. This suggests tyrosine phosphorylation regulates platelet phospholipase A2 activity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025
Same author

Voice and Swallowing Outcomes After Early Laryngeal Cancer: A UK Based Multi-Centre Study.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2025
Same author

Understanding the value of meningococcal vaccination for adolescents and young adults in the United States: insights from a steady-state modelling approach.

BMC public health·2025
Same author

A case-controlled trial evaluating the summative performance of the 3-D skills Model.

BMC medical education·2024
Same author

Structural dynamics around a hydrogen bond: Investigating the effect of hydrogen bond strengths on the excited state dynamics of carboxylic acid dimers.

The Journal of chemical physics·2024

Area of Science:

  • Biochemistry
  • Cell Biology
  • Hematology

Background:

  • Platelet activation involves protein phosphorylation, with a recent focus on tyrosine phosphorylation.
  • Understanding the role of tyrosine phosphorylation in platelet function is crucial for hemostasis and thrombosis research.

Purpose of the Study:

  • To investigate the role of tyrosine phosphorylation in human platelet activation using vanadate, an inhibitor of tyrosine phosphohydrolase.
  • To elucidate the signaling pathways involved in vanadate-induced platelet responses.

Main Methods:

  • Vanadate was used to induce platelet aggregation in saponin-permeabilized platelets.
  • Inhibitors like prostacyclin, genistein, aspirin, and BW755C were employed to block specific pathways.
  • Protein phosphorylation, phosphatidic acid formation, and arachidonic acid release were analyzed using biochemical techniques and immunoblotting.

Related Experiment Videos

Main Results:

  • Vanadate induced dose-dependent aggregation of permeabilized platelets, associated with phosphatidic acid formation and protein phosphorylation (pleckstrin, myosin light chain).
  • Vanadate caused tyrosine phosphorylation of several platelet proteins (26, 29, 32, 40, 42, 80, 90 kDa).
  • Vanadate stimulated arachidonic acid release, which was converted to thromboxane A2, leading to secondary platelet activation events.

Conclusions:

  • Vanadate stimulates platelet activation by promoting arachidonic acid release, potentially mediated by tyrosine phosphorylation of a platelet phospholipase A2 (possibly 80 or 90 kDa proteins).
  • The released arachidonic acid, converted to thromboxane A2, drives secondary platelet responses including aggregation and further protein phosphorylation.
  • Tyrosine phosphorylation of lower molecular weight proteins (26-42 kDa) is associated with these secondary activation events.